Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1628530-42-6N-(4-fluorophenyl)-N-(4-((7-hydroxy-6-methoxyquinolin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide

● In Stock

Catalogue No.:	VE0021565
CAS No.:	1628530-42-6
Mol. Formula:	C27H22FN3O5
Mol. Weight:	487.49 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 1628530-42-6

Parent drug

Cabozantinib

IUPAC Name

N-(4-Fluorophenyl)-N-(4-((7-hydroxy-6-methoxyquinolin-4-yl)oxy)phenyl)cyclopropane-1, 1-dicarboxamide

Pharmacopoeial Synonyms

N/A

Other Synonyms

Desmethylcabozantinib

Smiles

COC1=C(O)C=C(N=CC=C2OC3=CC=C(NC(C4(CC4)C(NC5=CC=C(F)C=C5)=O)=O)C=C3)C2=C1

InChI

InChI=1S/C27H22FN3O5/c1-35-24-14-20-21(15-22(24)32)29-13-10-23(20)36-19-8-6-18(7-9-19)31-26(34)27(11-12-27)25(33)30-17-4-2-16(28)3-5-17/h2-10, 13-15, 32H, 11-12H2, 1H3, (H, 30, 33)(H, 31, 34)

Description

N-(4-fluorophenyl)-N-(4-((7-hydroxy-6-methoxyquinolin-4-yl)oxy)phenyl)cyclopropane-1 | 1-dicarboxamide | also known as Desmethylcabozantinib | is a highly characterized reference material. It fully complies with stringent regulatory standards | including those set by USP | EMA | JP | and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial production of Cabozantinib. Moreover | it comes with a detailed Structure Elucidation Report (SER) | ensuring its accuracy and reliability for a wide range of analytical applications.